After receiving a green light earlier this year from the FDA, Medtronic has now collected a European approval for the latest ...

Medtronic announced today that it received CE mark approval for its Evolut FX+ transcatheter aortic valve implantation (TAVI) ...

Transscatheter aortic valve replacement is a novel way to replace a diseased aortic valve without a median sternotomy. The first human TAVR was performed by Dr. Cribier in 2002. [33] There have ...

With this expansion came a better understanding of associated complications. Spinal cord ischemia, perhaps the most dreaded complication of aortic surgery short of death, led to an understanding of ...

Edwards maintained its prior guidance for full-year sales growth of 8-10%, and expects Q4 sales of $1.33 billion to $1.39 ...

Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended Sept. 30, 2024. Highlights and Outlook ...

Objective: This study aimed to evaluate the feasibility and initial outcomes of totally endoscopic aortic valve replacement (TEAVR) performed via a single working port at the fourth intercostal space ...

Edwards Lifesciences on Thursday forecast fourth-quarter sales below Wall Street estimates, hurt by softer demand and fierce competition for its artificial heart valves. Investor expectations for ...

Cleveland Clinic Abu Dhabi, part of the M42 group, has successfully completed 500 Transcatheter Aortic Valve implantation ...

It was terrifying to face each day like that. Traditional surgery was ruled out because of my frailty, and I felt desperate ...